Ubiquitech Software Corp. (UBQU)
| Previous close | 0.0001 |
| Open | 0.0001 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0000 - 0.0001 |
| 52-week range | 0.0000 - 0.0001 |
| Volume | |
| Avg. volume | 28,224,220 |
| Market cap | 1.454M |
| Beta (5Y monthly) | 20.33 |
| PE ratio (TTM) | ∞ |
| EPS (TTM) | 0.0000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireUbiquitech Software's Subsidiary, Innovative Outcomes, Revolutionizes Healthcare Landscape With Clinic-Based Model, Anticipates Surge in Revenue Growth
DENVER, CO, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU), an innovative force in software development, is proud to announce a game-changing initiative by its subsidiary, Innovative Outcomes. The addition of a “Clinic-Based” focus to its business model represents a new era of exponential revenue growth, with each "Clinic Model" poised to inject an additional one million dollars annually into Innovative Outcomes' revenue stream. Embracing the Clinic-B
GlobeNewswireInnovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
Ubiquitech Software EZE Debride DENVER, CO, April 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to announce that its subsidiary, Innovative Outcomes, Inc., has entered into a distribution agreement with MDM Wound Ventures to distribute its new wound debriding system called EZE Debride to healthcare professionals throughout the US, and beyond. Wound Debriding is the process of removing dead
- GlobeNewswire
CEO of Innovative Outcomes, Inc., (OTC:UBQU) Offers Open Letter to Shareholders and Investors
DENVER, CO, March 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to offer this open letter to shareholders and investors from the CEO of its new subsidiary Innovative Outcomes, Inc. (Innovative Outcomes) a prominent player in the multi-billion-dollar medical wound care industry. CEO of Innovative Outcomes, Inc. Kevin Lamb: For the last 25 years my passion has focused on the medical industry;
